company background image
AT1 logo

Atomo Diagnostics ASX:AT1 Stock Report

Last Price

AU$0.025

Market Cap

AU$16.0m

7D

-10.7%

1Y

-19.4%

Updated

21 Jul, 2024

Data

Company Financials

Atomo Diagnostics Limited

ASX:AT1 Stock Report

Market Cap: AU$16.0m

AT1 Stock Overview

Engages in the development and sale of medical devices worldwide.

AT1 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Atomo Diagnostics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Atomo Diagnostics
Historical stock prices
Current Share PriceAU$0.025
52 Week HighAU$0.06
52 Week LowAU$0.021
Beta1.0
11 Month Change-7.41%
3 Month Change-16.67%
1 Year Change-19.35%
33 Year Change-87.50%
5 Year Changen/a
Change since IPO-93.59%

Recent News & Updates

Recent updates

We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Jul 05
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Oct 10
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

Jun 10
Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn

Dec 06
We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn

Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 01
Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate

We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow

Jul 19
We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow

Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)

Feb 26
Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)

Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

Jan 22
Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like

Dec 18
Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like

When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?

Jul 16
When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?

Shareholder Returns

AT1AU Medical EquipmentAU Market
7D-10.7%-0.1%0.05%
1Y-19.4%24.2%9.1%

Return vs Industry: AT1 underperformed the Australian Medical Equipment industry which returned 24.2% over the past year.

Return vs Market: AT1 underperformed the Australian Market which returned 9.1% over the past year.

Price Volatility

Is AT1's price volatile compared to industry and market?
AT1 volatility
AT1 Average Weekly Movement10.4%
Medical Equipment Industry Average Movement9.7%
Market Average Movement8.3%
10% most volatile stocks in AU Market16.7%
10% least volatile stocks in AU Market3.2%

Stable Share Price: AT1's share price has been volatile over the past 3 months.

Volatility Over Time: AT1's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/aJohn Kellyatomodiagnostics.com

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Atomo Diagnostics Limited Fundamentals Summary

How do Atomo Diagnostics's earnings and revenue compare to its market cap?
AT1 fundamental statistics
Market capAU$15.98m
Earnings (TTM)-AU$7.37m
Revenue (TTM)AU$3.11m

5.1x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AT1 income statement (TTM)
RevenueAU$3.11m
Cost of RevenueAU$1.94m
Gross ProfitAU$1.17m
Other ExpensesAU$8.53m
Earnings-AU$7.37m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Jul 31, 2024

Earnings per share (EPS)-0.012
Gross Margin37.49%
Net Profit Margin-237.01%
Debt/Equity Ratio0%

How did AT1 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.